1. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study
by Susan P. Whitman, Amy S. Ruppert, Guido Marcucci, Krzysztof Mrózek, Peter Paschka, Christian Langer, Claudia D. Baldus, Jing Wen, Tamara Vukosavljevic, Bayard L. Powell, Andrew J. Carroll, Jonathan E. Kolitz, Richard A. Larson, Michael A. Caligiuri, and Clara D. Bloomfield
Blood
Volume 109(12):
June 15, 2007
©2007 by American Society of Hematology

2. Overall survival and disease-free survival of CN-AML patients with MLL-PTD evaluated in this study.
Overall survival and disease-free survival of CN-AML patients with MLL-PTD evaluated in this study. Fifty percent of the patients are alive and 41% remain disease-free in CR1 beyond 2.5 years.
Susan P. Whitman et al. Blood 2007;109:
©2007 by American Society of Hematology